Hey Disinfonauts, I think I’ve mentioned this before, but everyone should absolutely check out this Divine Spark book that Graham Hancock just put out. It’s a great roundup of essays exploring the mind’s limitless imaginal potentiality as presented to us by the psychedelic experience (I’m pretty sure that sentence makes sense). The fact that psychedelic research is finally gaining more mainstream acceptance is, much like marijuana legalization, not something I ever thought I’d see in my lifetime. Back in my early 20’s I got popped for acid possession and was scoffed at for wanting to study these things as a psychology student. As bleak and out of touch as the world can seem at times, there are some deliciously weird things afoot. Let us never lose sight of that, or harp on the fact that this essay already appeared on the site a few years back. Is there ever a bad time to re-read through my stuff (or to read my book which you can grab super cheap)?… Read the rest
Tag Archives | MDMA
The folks at the Multidisciplinary Association for Psychedelic Studies (MAPS) did a Reddit AMA yesterday. I’ve curated some of the more informative questions and answers, but you can read the entire thread here.
MAPS introduces themselves with this lengthy but informative opening:
… Read the rest
We are the Multidisciplinary Association for Psychedelic Studies (MAPS), and we are here to educate the public about research into the risks and benefits of psychedelics and marijuana. MAPS is a 501(c)(3) non-profit research and educational organization founded in 1986 that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
We envision a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.
Some of the topics we’re passionate about include;
- Research into the therapeutic potential of MDMA, LSD, psilocybin, ayahuasca, ibogaine, and marijuana
- Integrating psychedelics and marijuana into science, medicine, therapy, culture, spirituality, and policy
- Providing harm reduction and education services at large-scale events to help reduce the risks associated with the non-medical use of various drugs
- Ways to communicate with friends, family, and the public about the risks and benefits of psychedelics and marijuana
- Our vision for a post-prohibition world
- Developing psychedelics and marijuana into prescription medicines through FDA-approved clinical research
List of participants:
- Rick Doblin, Ph.D., Founder and Executive Director, MAPS
- Brad Burge, Director of Communications and Marketing, MAPS
- Amy Emerson, Executive Director and Director of Clinical Research, MAPS Public Benefit Corporation
- Virginia Wright, Director of Development, MAPS
- Brian Brown, Communications and Marketing Associate, MAPS
- Sara Gael, Harm Reduction Coordinator, MAPS
- Natalie Lyla Ginsberg, Research and Advocacy Coordinator, MAPS
- Tess Goodwin, Development Assistant, MAPS
- Ilsa Jerome, Ph.D., Research and Information Specialist, MAPS Public Benefit Corporation
- Sarah Jordan, Publications Associate, MAPS
- Bryce Montgomery, Web and Multimedia Associate, MAPS
- Shannon Clare Petitt, Executive Assistant, MAPS
- Linnae Ponté, Director of Harm Reduction, MAPS
- Ben Shechet, Clinical Research Associate, MAPS Public Benefit Corporation
- Allison Wilens, Clinical Study Assistant, MAPS Public Benefit Corporation
- Berra Yazar-Klosinski, Ph.D., Clinical Research Scientist, MAPS
For more information about scientific research into the medical potential of psychedelics and marijuana, visitmaps.org.
Eyes are the window to your soul, and that doesn’t stop being true no matter how many illegal substances you consume on a night out. But can your eyes really tell when you’re actually on something? From pupils the size of a needlepoint to huge black holes with barely visible irises, we snapped our way through Berlin’s nightclubs to see if people’s eyeballs could tell us the night’s story. How much does the size of your pupils actually have to do with the substances you’ve taken?
The stuff in drugs that makes you relaxed, happy or just really awake not only manipulates the neurotransmitters in your brain, but can also affect physiological processes in your body. This includes the muscles in your eyes that are responsible for making your pupils bigger (to let in more light, for example), or smaller.
To see more eyes and read more, go here: http://www.vice.com/read/can-you-tell-what-drugs-someones-on-just-by-looking-at-their-eyes-876
What does MDMA actually do to your brain?
Attitudes towards the healing powers of psychedelics seem to be changing, says Tom Shroder, the author of a new book on the subject. And, according to some researchers, their incredible efficacy is due to their ability to unleash the mind’s own “innate healing intelligence”.
The award winning journalist and ex-editor of The Washington Post Magazine spoke to The Eternities podcast about his latest work, Acid Test: LSD, Ecstasy and the Power to Heal, which looks at the history of psychedelic therapy from the fifties to the present day.
He said, “Our system, as biased as it might have been against psychedelics, certainly was based on [a] belief that science could prove something, and science [has been] proving the efficacy of these drugs … in clinical conditions. They’re plenty safe enough. In fact, they’re much safer than most other drugs used in psychiatry. So, you can’t argue with the science.”
One of the three main figures in the book is Dr Michael Mithoefer, a psychiatrist at the forefront of psychedelic therapy research.… Read the rest
Tom Shroder, author of Acid Test: LSD, Ecstasy, and the Power to Heal, tells the story of Nick, a veteran haunted by PTSD in an interview with The Daily Beast in which he relates why psychedelics are so important to veterans, and the roadblocks researchers face getting it to them:
… Read the rest
LSD, an illicit drug with a serious stigma, was once the darling of the psychotherapy world.
Synthesized by Swiss chemist Albert Hofmann in 1938, the two decades following its birth were populated with study after study showing positive effects. With its ability to reduce defensiveness, help users relive early experiences, and make unconscious material accessible, it proved tremendously successful in therapy.
In a plethora of studies from the 1950s, researchers found the drug, and other psychedelics in its family, to be successful in treating victims of psychosomatic illnesses ranging from depression to addiction. With fear and hesitation stripped away, psychologists could help their patients dive headfirst into a painful memory, feeling, or thought, and work through it.
“There really has been an exponential increase of media interest in what’s happening. I think that’s the result of new research, (and) the result of some major international conferences that are really establishing the field of psychedelic science and medicine.” Brad Burge of MAPS.
It seems we’re finally at a turning point in The War on Drugs. All it took was a few decades of indoctrination, mass-incarceration, astronomical price tags and straight-up horrific body counts. Yet, society’s transition into a deeper understanding of these substances has been far from smooth. Yes, the people have clearly spoken on the subject of marijuana, and nearly half of all U.S. states have taken notice, putting some sort of marijuana-friendly law on the books. However, when it comes to Mary Jane’s more potent psychedelic cousins, the conversation is quite a bit more nuanced and controversial. Thankfully, for the first time in decades, the dialogue surrounding psychedelics is evolving.… Read the rest
I always thought Molly/Ecstasy turned you into a blissed out hug-loving moron, but apparently it turns us into blissed out racists instead. From VICE:
… Read the rest
You don’t have a lot of time for rational thought after dropping a pill. Three Mitsis in and you’re almost entirely preoccupied with finding out what people’s scarves feel like, or busy trying to focus on literally anything through your rapid-fire flicker-eyes. So you’d have thought that, amid all the euphoria and heart palpitations, there surely wouldn’t be space to get hung up on the ethnicity of everyone around you.
However, it turns out that the brain’s biochemistry during a blissed out club night might not be too dissimilar from a rally during the EDL’s golden years. This is because of a hormone called oxytocin, which has been described by many as “the love hormone” or the “cuddle drug”. The hormone has been linked to developing trust between mother and child during breast feeding, and between partners after intercourse.
Abby Martin speaks with Alex & Allyson Grey, the most prolific psychedelic artists in the world, discussing the role of transcendentalism, spirituality and entheogenic drugs have played in their art and personal lives, as well as their work on the Chapel of Sacred Mirrors.
Please support and help spread awareness of MAPS (Multidisciplinary Association for Psychedelic Studies) research. MDMA studies are foot in the door for a big change in psychedelic drug policies worldwide. Not to mention its an incredible psycho-therapeutic tool on its own, capable of helping millions.
In a recently completed study, 83% of subjects receiving MDMA-assisted psychotherapy no longer qualified for PTSD, and everyone who received a placebo and then went on to receive MDMA-assisted psychotherapy experienced significant and lasting improvements. These results were published in the Journal of Psychopharmacology. These subjects had suffered from PTSD for an average of 19 years.